Description
Tirzepatide is a 39-amino-acid synthetic peptide that activates both the GIP and GLP-1 receptors — the “twincretin” design. As an approved medicine elsewhere, it serves research settings as a reference compound for dual-incretin pharmacology.
The research literature spans insulin secretion dynamics, appetite signalling, gastric emptying and adipose metabolism, with particular interest in why dual receptor activation outperforms single-pathway agonists in metabolic models.
Format & handling
Supplied as a lyophilized powder in a sealed, batch-stamped vial. Store sealed at −20 °C protected from light. For laboratory work, reconstitute with bacteriostatic water shortly before use and refrigerate any working solution at 2–8 °C.
For laboratory research use only — not for human or veterinary use. The summary above describes published research for scientific context and makes no claims about this product.
